The X Protein of Hepatitis B Virus Coactivates Potent Activation Domains
Open Access
- 1 February 1995
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 15 (2) , 1079-1085
- https://doi.org/10.1128/mcb.15.2.1079
Abstract
Transactivation by hepatitis B virus X protein (pX) is promiscuous, but it requires cellular activators. To study the mode of action of pX, we coexpressed pX with Gal4-derived activators in a cotransfection system. Twelve different activators bearing different types of activation domains were compared for their response to pX. Because pX indirectly increases the amount of the activators, tools were developed to compare samples with equivalent amount of activators. We demonstrate that pX preferentially coactivates potent activators, especially those with acidic activation domains. Weak activators with nonacidic activation domains are not potentiated by pX. Interestingly, Gal4E1a, which is not rich in acidic residues but interacts with similar molecular targets, also responds to pX. The response to pX correlated with the strength of the activation domain. Collectively, these data imply that pX is a coactivator, which offers a molecular basis for the pleiotropic effects of pX on transcription.Keywords
This publication has 74 references indexed in Scilit:
- Functional and structural similarity between the X protein of hepatitis B virus and nucleoside diphosphate kinasesFEBS Letters, 1994
- The hepatitis B virus transactivator HBx causes elevation of diacylglycerol and activation of protein kinase CResearch in Virology, 1993
- Pleiotropy and henchman XNature, 1993
- PCF4 encodes an RNA polymerase III transcription factor with homology to TFIIBCell, 1992
- Threshold Phenomena and Long-Distance Activation of Transcription by RNA Polymerase IIScience, 1992
- Dr1, a TATA-binding protein-associated phosphoprotein and inhibitor of class II gene transcriptionCell, 1992
- Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cMYC protooncogene at the transcriptional levelBiochemical and Biophysical Research Communications, 1991
- X Protein of Hepatitis B Virus Resembles a Serine Protease InhibitorJapanese Journal of Cancer Research, 1990
- Mechanism of transcriptional activation by Sp1: Evidence for coactivatorsCell, 1990
- GAL4-VP16 is an unusually potent transcriptional activatorNature, 1988